Cargando…
Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in patients with advanced cancer?
Autores principales: | Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670748/ https://www.ncbi.nlm.nih.gov/pubmed/26674220 http://dx.doi.org/10.1002/jcsm.12080 |
Ejemplares similares
-
The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients
por: Saitoh, Masakazu, et al.
Publicado: (2016) -
Growth differentiation factor‐15 as a prognostic biomarker in cancer patients
por: Ishida, Junichi, et al.
Publicado: (2016) -
Irisin – a myokine potentially bridging muscle and fat tissue in cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015) -
Considering technique of assessment and method for normalizing skeletal muscle mass
por: Saitoh, Masakazu, et al.
Publicado: (2017) -
Concern regarding quality and quality of muscle
por: Saitoh, Masakazu, et al.
Publicado: (2015)